Search - tctmd.com

Displaying 161 - 180 of 359

Sort: Relevancy | Date

Presentation TCT 2017

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No!

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation TCT 2017

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Presenter: Lee N. Benson, Megan Coylewright, Guillaume Turc

November 01, 2017

Presentation TCT 2017

Case Study #1 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, Steven L. Goldberg

November 01, 2017

Presentation TCT 2017

Case Study #1 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, Steven L. Goldberg

November 01, 2017

Presentation TCT 2017

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

Presenter: Lee N. Benson, Megan Coylewright

November 01, 2017

Presentation TCT 2017

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation TCT 2017

The PFO Clinic: Neurologists and Cardiologists as a Team

Presenter: Lee N. Benson, Megan Coylewright, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage III - FDA Perspective

Presenter: Robert J. Sommer, David L. Tirschwell, Andrew Farb

November 01, 2017

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Patient Advocates Perspective

Presenter: Robert J. Sommer, David L. Tirschwell, Bray Patrick-Lake

November 01, 2017

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Cardiology Perspective

Presenter: Robert J. Sommer, David L. Tirschwell, John D. Carroll

November 01, 2017

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage I - Neurology Perspective

Presenter: Robert J. Sommer, David L. Tirschwell

November 01, 2017

Presentation TCT 2017

Pivotal PFO Stroke Trial Update I: REDUCE

Presenter: Robert J. Sommer, David L. Tirschwell, John F. Rhodes

November 01, 2017

Presentation TCT 2017

Pivotal PFO Stroke Trial Update II: CLOSE

Presenter: Robert J. Sommer, David L. Tirschwell, Guillaume Turc

November 01, 2017

Presentation TCT 2017

Pivotal PFO Stroke Trial Update I: RESPECT

Presenter: Robert J. Sommer, David L. Tirschwell

November 01, 2017

Presentation TCT 2017

Percutaneous Suture-mediated Patent Foramen Ovale (PFO) Closure: Early Results With NobleStitchEL Device

Presenter: Daniel Burkhoff, Samir R. Kapadia, Achille Gaspardone

November 01, 2017

News Conference News TCT 2017

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

Transcatheter Closure of a Sinus Venosus ASD With Partial Anomalous Pulmonary Venous Connection

Presenter: Vasilis Babaliaros, Shmuel Banai, John P. Breinholt

October 30, 2017

Presentation TCT 2017

Effect of Slender vs Standard Sheath on Radial Artery Occlusion: The RAP and BEAT Trial

Presenter: Prashant Kaul, Jennifer A. Tremmel, Shigeru Saito

October 30, 2017

Presentation TCT 2017

PFO Closure in Cryptogenic Stroke

Presenter: David Hildick-Smith, Lars Sondergaard

October 29, 2017

Advertisement

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No!

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Case Study #1 Resolution: How We Treated, and Long-term Outcome

Case Study #1 Introduction: To Close or Not to Close?

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

The PFO Clinic: Neurologists and Cardiologists as a Team

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage III - FDA Perspective

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Patient Advocates Perspective

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Cardiology Perspective

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage I - Neurology Perspective

Pivotal PFO Stroke Trial Update I: REDUCE

Pivotal PFO Stroke Trial Update II: CLOSE

Pivotal PFO Stroke Trial Update I: RESPECT

Percutaneous Suture-mediated Patent Foramen Ovale (PFO) Closure: Early Results With NobleStitchEL Device

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Transcatheter Closure of a Sinus Venosus ASD With Partial Anomalous Pulmonary Venous Connection

Effect of Slender vs Standard Sheath on Radial Artery Occlusion: The RAP and BEAT Trial

PFO Closure in Cryptogenic Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content